EUSA names new CEO
This article was originally published in Scrip
EUSA Pharma, a recently established specialty pharmaceutical company, has named Lee Morley CEO and Dr Göran Ando non-executive director. Mr Morley joins EUSA from Jazz Pharmaceuticals, where he was vice-president and head of commercial for Europe and international markets. At Jazz, Mr Morley had responsibility for the original EUSA Pharma business following its acquisition in 2012, until the recent launch of EUSA as a newly established independent company. He has also previously held a number of management positions in sales and marketing at Merck Sharp and Dohme.
You may also be interested in...
In the latest instalment of our VC playbook series, In Vivo sits down with Roel Bulthuis, managing partner at INKEF Capital, to discuss the group’s approach to health care investing in Europe, the importance of funding a team not just a project and how life sciences venture capital is evolving with the emergence of health tech.
Our readers have been voting and the results have been counted. The winners of In Vivo's annual Deals Of The Year contest are ...
It is time for In Vivo's 12th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.